Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  3,730 results for ""VACCINE development""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Periodical

The CEO of Pfizer on Developing a Vaccine in Record Time.

Subjects: COVID-19 vaccines; PFIZER Inc.; BIONTECH SE

  • Source: Harvard Business Review. May/Jun2021, Vol. 99 Issue 3, p34-39. 6p. 3 Color Photographs, 1 Graph.

  • Abstract: On March 19, 2020, as Covid-19 swept across the world, Bourla challenged everyone at Pfizer and its partner BioNTech—a German company focused on cancer immunotherapies—to “... Copyright 2021 Harvard Business Publishing. All Rights Reserved. Additional restrictions may apply including the use of this content as assigned course material. Please consult your ...

Record details

×
Academic Journal

Structures of Foot-and-mouth Disease Virus with neutralizing antibodies derived from recovered natural host reveal a mechanism for cross-serotype neutralization.

Subjects: *VIRUS diseases; *VACCINE development; *ANIMAL diseases

  • Source: PLoS Pathogens. 4/28/2021, Vol. 17 Issue 4, p1-20. 20p.

  • Abstract: The development of a universal vaccine against foot-and-mouth disease virus (FMDV) is hindered by cross-serotype antigenic diversity ... Copyright of PLoS Pathogens is the property of Public Library of Science and its content may not be copied or emailed to multiple sites ...

Record details

×
Academic Journal

Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.

Subjects: *SARS-CoV-2; *VACCINE development; *VIRAL proteins

  • Source: BMC Bioinformatics. 4/8/2021, Vol. 22 Issue 1, p1-18. 18p.

  • Abstract: Background: The rapid spread of the COVID-19 demands immediate response from the scientific communities. Appropriate countermeasures mean thoughtful and educated choice of viral targets (epitopes). ... Copyright of BMC Bioinformatics is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted ...

Record details

×
Academic Journal

Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.

Subjects: *TUMOR antigens; *VACCINE development; *CHOLANGIOCARCINOMA

  • Source: Molecular Cancer. 3/8/2021, Vol. 20 Issue 1, p1-17. 17p.

  • Abstract: Background: The mRNA-based cancer vaccine has been considered a promising strategy and the next hotspot in cancer immunotherapy. However, its application ... Copyright of Molecular Cancer is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted ...

Record details

×
Academic Journal

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.

Subjects: *TUMOR antigens; *VACCINE development; *ANTIGEN presenting cells

  • Source: Molecular Cancer. 3/1/2021, Vol. 20 Issue 1, p1-18. 18p.

  • Abstract: Background: Although mRNA vaccines have been effective against multiple cancers, their efficacy against pancreatic adenocarcinoma (PAAD) remains undefined. Accumulating evidence suggests that immunotyping can indicate ... Copyright of Molecular Cancer is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted ...

Record details

×
Academic Journal

Frontrunners in the race to develop a SARS-CoV-2 vaccine.

Subjects: *VACCINE development; *COVID-19 pandemic; *GENETIC vectors

  • Source: Canadian Journal of Microbiology. 2021, Vol. 67 Issue 3, p189-212. 24p.

  • Abstract: Numerous studies continue to be published on the COVID-19 pandemic that is being caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Given the rapidly ... De nombreuses études continuent d'être publiées sur la pandémie de la COVID-19 causée par le coronavirus 2 du syndrome respiratoire aigu sé... Copyright of Canadian Journal of Microbiology is the property of Canadian Science Publishing and its content may not be copied or emailed to multiple ...

Record details

×
Periodical

MESSENGER RNA VACCINES.

Subjects: *MESSENGER RNA; *VACCINE development; *DRUG developmentMODERNA Inc. ; BIONTECH SE ; PFIZER Inc. 001326495 PFIZER Inc. PFIZER Inc. 001326495 001326495 PFIZER Inc. 001326495 PFE

  • Source: MIT Technology Review. Mar/Apr2021, Vol. 124 Issue 2, p28-33. 6p. 4 Color Photographs.

  • Abstract: The article focuses on the messenger RNA technology used to develop vaccines for the coronavirus disease COVID-19 and how this type of therapeutic may change ...

Record details

×
Academic Journal

Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development.

Subjects: *COVID-19; *VACCINE development; *VIRAL transmission

  • Source: Asian Journal of Pharmaceutical Sciences. Jan2021, Vol. 16 Issue 1, p4-23. 20p.

  • Abstract: SARS-CoV-2 has been marked as a highly pathogenic coronavirus of COVID-19 disease into the human population, causing over 5.5 million confirmed cases worldwide. As COVID-19 has ... Copyright of Asian Journal of Pharmaceutical Sciences is the property of Asian Journal of Pharmaceutical Sciences and its content may not be copied or ...

Record details

×
Academic Journal

Coronavirus vaccine development: from SARS and MERS to COVID-19.

Subjects: *COVID-19; *VACCINE development; *MERS coronavirus

  • Source: Journal of Biomedical Science. 12/20/2020, Vol. 27 Issue 1, p1-23. 23p.

  • Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the most challenging pandemic ... Copyright of Journal of Biomedical Science is the property of BioMed Central and its content may not be copied or emailed to multiple sites ...

Record details

×
  • 1-10 of  3,730 results for ""VACCINE development""